A new approach to the stereospecific synthesis of phospholipids. The use of L-glyceric acid for the preparation of diacylglycerols, phosphatidylcholines, and related derivatives

Journal of Organic Chemistry

Volumn 64, Issue 21, 1999, Pages 7727-7737

  Roodsari, Farzaneh S ^a   Wu, Dongpei ^a   Pum, Gregory S ^a   Hajdu, Joseph ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; DIACYLGLYCEROL; GLYCERIC ACID; OXYGEN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SULFUR; TRIMETHYLAMINE;

ARTICLE; CHEMICAL REACTION KINETICS; CHIRALITY; PHOSPHOLIPID METABOLISM; PHOSPHORYLATION; PHYSICAL CHEMISTRY; STEREOISOMERISM; STEREOSPECIFICITY; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 0032741250     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo990414e     Document Type: Article

References (72)

1. (a) Menger, F. M.; Angelova, M. I. Acc. Chem. Res. 1998, 31, 789.
2. (b) Eibl, H. Angew. Chem., Intl. Ed. 1984, 23, 257.
3. Dowhan, W. Annu. Rev. Biochem. 1997, 66, 199.
4. Snyder, F. Proc. Soc. Exp. Biol. Med. 1989, 190, 125.
5. Chao, W.; Olson, M. S. Biochem. J. 1993, 292, 617.
6. Nishizuka, Y. Science 1992, 258, 607.
7. Hirata, F.; Axelrod, J. Science 1980, 209, 1082.
8. (a) Snyder, F.; Lee, T.-C.; Blank, M. L. Prog. Lipid Res. 1992, 31, 65.
9. (b) MacDonald, J. I. S.; Sprecher, H. Biochim. Biophys. Acta 1991, 1084, 105.
10. (a) Bodine, P. V.; Garcia, M. L.; Pascual, J.; Bastida, E.; Carganico, G.; Litwack, G. Receptor 1991, 1, 167.
11. (b) Schulman, G.; Bodine, P. V.; Litwack, G. Biochemistry 1990, 31, 1734.
12. Sanson, A.; Monck, M. A.; Neumann, J.-M. Biochemistry 1995, 34, 5938.
13. Senisterra, G.; Epand, R. M. Arch. Biochem. Biophys. 1993, 300, 378
14. Buchner, K. Eur. J. Biochem. 1995, 228, 211.
15. (a) Balsinde, J.; Dennis, E. A. J. Biol. Chem. 1996, 271, 6758.
16. (b) Balboa, M. A.; Balsinde, J.; Winstead, M. V.; Tischfeld, J. A.; Dennis, E. A. J. Biol. Chem. 1996, 271, 32381.
17. (a) Vigmond, S. S.; Dewa, T.; Regen, S. L. J. Am. Chem. Soc. 1995, 117, 7838.
18. (b) Dewa, T.; Regen, S. L. J. Am. Chem. Soc. 1996, 118, 7069.
19. Carion-Taravella, B.; Lesieur, S.; Ollivon, M.; Chopineau, J. J. Am. Chem. Soc. 1998, 120, 10588.
20. Tocanne, J.-F.; Dupou-Cezanne, L.; Lopez, A. Prog. Lipid Res. 1994, 33, 203.
21. White, J. M. Science 1992, 258, 917.
22. Sandermann, H.; Duncan, T. M.; McIntyre, J. O.; Fleischer, S. In Protein-Lipid Interactions; Watts, A., Ed.; Elsevier: Amsterdam, 1993; p 67.
23. Bittman, R. In Phospholipid Handbook; Cerc, G., Ed.; Marcel Dekker: New York, 1993; p 141.
24. Hebert, N.; Beck, A.; Lennox, R. B.; Just, G. J. Org. Chem. 1992, 57, 1777.
25. (a) Martin, S. F.; Josey, J. A.; Wong, V.-L.; Dean, D. W. J. Org. Chem. 1994, 59, 4805.
26. (b) Martin, S. F.; Josey, J. A. Tetrahedron Lett. 1988, 29, 3631.
27. (a) Srisiri, W.; Lee, Y.-S.; O'Brien, D. F. Tetrahedron Lett. 1995, 36, 8945.
28. (b) Srisiri, W.; Lamparski, H. G.; O'Brien, D. F. J. Org. Chem. 1996, 61, 5911.
29. Burgos, C. E.; Ayer, D. E.; Johnson, R. A. J. Org. Chem. 1987, 52, 4973.
30. Ali, S.; Bittman, R. J. Org. Chem. 1988, 53, 5547.
31. Kim, U. T.; Hajdu, J. J. Chem. Soc., Chem. Commun. 1993, 70.
32. Kazi, A. B.; Hajdu, J. Tetrahedron Lett. 1992, 32, 2291.
33. Srivastava, R. P.; Hajdu, J. Tetrahedron Lett. 1991, 31, 6525.
34. Katsuki, J.; Sharpless, B. K. J. Am. Chem. Soc. 1980, 102, 5976.
35. (a) Bhatia, S. K.; Hajdu, J. J. Org. Chem. 1988, 53, 5034.
36. (b) Bhatia, S. K.; Hajdu, J. Tetrahedron Lett. 1987, 28, 271.
37. 4 could also be accomplished in high yield, substantial losses occurred on isolation of the product, most likely as a result of chelation of aluminum by the bis-diol function of compound 6.
38. 19-21 resulted in lower yields as well: compound 7b was obtained in 43% along with the sn-2-regioisomer (10%) and the 1,2-diacyl product (8.1%), compared to the 71% yield obtained under the reaction conditions shown in Scheme 1.
39. 1H NMR spectra of phosphatidylcholines and related derivatives, see: Sparling, M. L.; Zidovetzki, R.; Muller, L.; Chan, S. I. Anal. Biochem. 1989, 178, 67.
40. We observed no significant acyl migration during the workup and subsequent chromatography.
41. Mosher, H. S.; Dale, J. A.; Dull, D. L. J. Org. Chem. 1969, 34, 2543.
42. (a) Clingman, K. A.; Hajdu, J. J. Chem. Educ. 1987, 64, 358.
43. (b) Balet, C.; Clingman, K. A.; Hajdu, J. Biochem. Biophys. Res. Commun. 1988, 150, 561.
44. Byun, H.-S.; Erukulla, R. K.; Bittman, R. J. Org. Chem., 1994, 56, 2630.
45. Medeiros, E.; Herbert, J. M.; Taylor, R. J. K. Tetrahedron Lett. 1990, 31, 5843.
46. (a) Kishi, Y.; Rando, R. R. Acc. Chem. Res. 1998, 31, 163.
47. (b) Ganong, B. R.; Loomis,; Hannun, Y. A.; Bell, R. M. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 1184.
48. (a) Homayoun, P.; Stacey, D. W. Biochem. Biophys. Res. Commun. 1993, 195, 144.
49. (b) McElhaney, R. N. Curr. Top. Membr. Transport 1982, 17, 317.
50. It has been well documented that both naturally occurring and synthetic phospholipids show significant changes in response to variation of the polar phosphoester substituent in thermotropic properties (cf. Chowdry, B. Z.; Lipka, G.; Dalziel, A. W.; Sturtevant, J. M. Biophys. J. 1984, 45, 901) enzyme-substrate behavior (Roberts, M. F.; Deems, R. A.; Dennis, E. A. J. Biol. Chem. 1977, 525, 2405), inhibitory potency (Yu, L.; Deems, R. A.; Hajdu, J.; Dennis, E. A. J. Biol. Chem. 1990, 265, 2657. DeHaas, G. H.; Dijkman, R.; Ransac, S.; Verger, R. Biochim. Biophys. Acta 1990, 1046, 249), and antitumor activity (Hoffman, D. R.; Hajdu, J.; Snyder, F. Blood 1984, 63, 545). For a recent application of headgroup-modified phospholipids in the design of new drug delivery systems, see: Wang, P.; Schuster, M.; Wang, Y.-F.; Wong, C.-H. J. Am. Chem. Soc. 1993, 115, 10487.
51. It has been well documented that both naturally occurring and synthetic phospholipids show significant changes in response to variation of the polar phosphoester substituent in thermotropic properties (cf. Chowdry, B. Z.; Lipka, G.; Dalziel, A. W.; Sturtevant, J. M. Biophys. J. 1984, 45, 901) enzyme-substrate behavior (Roberts, M. F.; Deems, R. A.; Dennis, E. A. J. Biol. Chem. 1977, 525, 2405), inhibitory potency (Yu, L.; Deems, R. A.; Hajdu, J.; Dennis, E. A. J. Biol. Chem. 1990, 265, 2657. DeHaas, G. H.; Dijkman, R.; Ransac, S.; Verger, R. Biochim. Biophys. Acta 1990, 1046, 249), and antitumor activity (Hoffman, D. R.; Hajdu, J.; Snyder, F. Blood 1984, 63, 545). For a recent application of headgroup-modified phospholipids in the design of new drug delivery systems, see: Wang, P.; Schuster, M.; Wang, Y.-F.; Wong, C.-H. J. Am. Chem. Soc. 1993, 115, 10487.
52. It has been well documented that both naturally occurring and synthetic phospholipids show significant changes in response to variation of the polar phosphoester substituent in thermotropic properties (cf. Chowdry, B. Z.; Lipka, G.; Dalziel, A. W.; Sturtevant, J. M. Biophys. J. 1984, 45, 901) enzyme-substrate behavior (Roberts, M. F.; Deems, R. A.; Dennis, E. A. J. Biol. Chem. 1977, 525, 2405), inhibitory potency (Yu, L.; Deems, R. A.; Hajdu, J.; Dennis, E. A. J. Biol. Chem. 1990, 265, 2657. DeHaas, G. H.; Dijkman, R.; Ransac, S.; Verger, R. Biochim. Biophys. Acta 1990, 1046, 249), and antitumor activity (Hoffman, D. R.; Hajdu, J.; Snyder, F. Blood 1984, 63, 545). For a recent application of headgroup-modified phospholipids in the design of new drug delivery systems, see: Wang, P.; Schuster, M.; Wang, Y.-F.; Wong, C.-H. J. Am. Chem. Soc. 1993, 115, 10487.
53. It has been well documented that both naturally occurring and synthetic phospholipids show significant changes in response to variation of the polar phosphoester substituent in thermotropic properties (cf. Chowdry, B. Z.; Lipka, G.; Dalziel, A. W.; Sturtevant, J. M. Biophys. J. 1984, 45, 901) enzyme-substrate behavior (Roberts, M. F.; Deems, R. A.; Dennis, E. A. J. Biol. Chem. 1977, 525, 2405), inhibitory potency (Yu, L.; Deems, R. A.; Hajdu, J.; Dennis, E. A. J. Biol. Chem. 1990, 265, 2657. DeHaas, G. H.; Dijkman, R.; Ransac, S.; Verger, R. Biochim. Biophys. Acta 1990, 1046, 249), and antitumor activity (Hoffman, D. R.; Hajdu, J.; Snyder, F. Blood 1984, 63, 545). For a recent application of headgroup-modified phospholipids in the design of new drug delivery systems, see: Wang, P.; Schuster, M.; Wang, Y.-F.; Wong, C.-H. J. Am. Chem. Soc. 1993, 115, 10487.
54. It has been well documented that both naturally occurring and synthetic phospholipids show significant changes in response to variation of the polar phosphoester substituent in thermotropic properties (cf. Chowdry, B. Z.; Lipka, G.; Dalziel, A. W.; Sturtevant, J. M. Biophys. J. 1984, 45, 901) enzyme-substrate behavior (Roberts, M. F.; Deems, R. A.; Dennis, E. A. J. Biol. Chem. 1977, 525, 2405), inhibitory potency (Yu, L.; Deems, R. A.; Hajdu, J.; Dennis, E. A. J. Biol. Chem. 1990, 265, 2657. DeHaas, G. H.; Dijkman, R.; Ransac, S.; Verger, R. Biochim. Biophys. Acta 1990, 1046, 249), and antitumor activity (Hoffman, D. R.; Hajdu, J.; Snyder, F. Blood 1984, 63, 545). For a recent application of headgroup-modified phospholipids in the design of new drug delivery systems, see: Wang, P.; Schuster, M.; Wang, Y.-F.; Wong, C.-H. J. Am. Chem. Soc. 1993, 115, 10487.
55. It has been well documented that both naturally occurring and synthetic phospholipids show significant changes in response to variation of the polar phosphoester substituent in thermotropic properties (cf. Chowdry, B. Z.; Lipka, G.; Dalziel, A. W.; Sturtevant, J. M. Biophys. J. 1984, 45, 901) enzyme-substrate behavior (Roberts, M. F.; Deems, R. A.; Dennis, E. A. J. Biol. Chem. 1977, 525, 2405), inhibitory potency (Yu, L.; Deems, R. A.; Hajdu, J.; Dennis, E. A. J. Biol. Chem. 1990, 265, 2657. DeHaas, G. H.; Dijkman, R.; Ransac, S.; Verger, R. Biochim. Biophys. Acta 1990, 1046, 249), and antitumor activity (Hoffman, D. R.; Hajdu, J.; Snyder, F. Blood 1984, 63, 545). For a recent application of headgroup-modified phospholipids in the design of new drug delivery systems, see: Wang, P.; Schuster, M.; Wang, Y.-F.; Wong, C.-H. J. Am. Chem. Soc. 1993, 115, 10487.
56. Slater, S. J.; Kelly, M. B.; Taddeo, F. J.; Ho, C.; Rubin, E.; Stubbs, C. D. J. Biol. Chem. 1994, 269, 4866.
57. Dowhan, W.; Bogdanov, M. Chem. Phys. Lipids 1998, 94, 149.
58. Thunnissen, M. M. G. M.; Ab, E.; Kalk, K. H.; Drenth, J.; Dijkstra, B. W.; Kuipers, O. P.; Dijkman, R.; de Haas, G. H.; Verheij, H. M. Nature 1990, 347, 689.
59. Wu, S. M.; Qureshi, A.; Hajdu, J., unpublished results.
60. (a) Stryer, L. Annu. Rev. Biochem. 1978, 47, 819.
61. (b) Cevc, G.; Seddon, J. M. In Phospholipid Handbook; Cevc, G., Ed.; Marcel Dekker: New York, 1993; pp 351-401.
62. Nichols, J. W.; Pagano, R. E. Biochemistry 1982, 21, 1720.
63. Eftink, M. R. In Biophysical and Biochemical Aspects of Fluorescent Spectroscopy; Dewey, T. G., Ed.; Plenum Press: New York, 1991; Chapter 1.
64. Janout, V.; Lanier, M.; Regen, S. L. J. Am. Chem. Soc. 1996, 118, 1573.
65. (a) Lee, Y. C.; Lee, R. T. Acc. Chem. Res. 1995, 28, 321.
66. (b) The absorption spectrum of the dansyl chromophore overlaps with the emission spectra of β-naphthylacetyl group. The N-methylanthranoyl fluorophore also absorbs at the emission maximum of the β-naphthylacetyl sprctrum (see the Experimental Section).
67. (a) Bales, B. L.; Stenland, C. J. Phys. Chem. 1993, 97, 3418.
68. (b) Bales, B. L., personal communication.
69. Nitroxide spin labels are known to be unstable under acidic conditions; see: Cardellini, L.; Carloni, P.; Damian, E.; Greci, L.; Stipa, P.; Rizzoli, C.; Sgarabatto, P. J. Chem Soc., Perkin Trans. 2 1994, 769.
70. Dittmer, J. C.; Lester, R. L. J. Lipid Res. 1964, 5, 126.
71. Selinger, Z.; Lapidot, Y. J. Lipid Res. 1966, 7, 174.
72. The p-nitrophenyl eater of 12-TCBOC-aminolauric acid was prepared in reaction between 12-TCBOC-aminolauric acid and p-nitrophenol using DCC as coupling agent.